Repligen (NASDAQ: RGEN) director granted RSUs and options in equity award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
REPLIGEN CORP director Glenn P. Muir reported routine equity compensation awards. He received 995 restricted stock units, each representing one share of common stock, which vest in full on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual shareholder meeting.
Muir also received stock options covering 2,239 shares of common stock at an exercise price of $103.38 per share, expiring on May 14, 2036, with the same vesting schedule. Following these awards, he holds 40,051 shares of common stock directly and 2,239 stock options. The RSUs will be settled in shares after his service as a director ends, in line with his deferral election.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
MUIR GLENN P
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,239 | $0.00 | -- |
| Grant/Award | Common Stock | 995 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,239 shares (Direct, null);
Common Stock — 40,051 shares (Direct, null)
Footnotes (1)
- Mr. Muir was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The Reporting Person has elected to defer settlement of these restricted stock units pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the separation of the Reporting Person's service as a Director. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.
Key Figures
Restricted stock units granted: 995 units
Stock options granted: 2,239 options
Option exercise price: $103.38/share
+4 more
7 metrics
Restricted stock units granted
995 units
Equity award to director Glenn P. Muir on May 14, 2026
Stock options granted
2,239 options
New option award to director on May 14, 2026
Option exercise price
$103.38/share
Strike price for 2,239 stock options
Option expiration date
May 14, 2036
Expiration for newly granted stock options
Shares held after transaction
40,051 shares
Common stock directly owned by Muir post-award
Options held after transaction
2,239 options
Total options reported following the grant
RSU vesting date reference
May 14, 2027
Earliest full vesting date for RSUs and options
Key Terms
restricted stock units, Deferred Compensation Plan for Non-Employee Directors, Stock Option (Right to Buy), vests in full, +1 more
5 terms
restricted stock units financial
"Mr. Muir was awarded 995 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Deferred Compensation Plan for Non-Employee Directors financial
"The Reporting Person has elected to defer settlement ... pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors."
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
vests in full financial
"Award vests in full on the earlier of May 14, 2027, one year from grant date..."
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock."
FAQ
What insider transactions did REPLIGEN CORP (RGEN) director Glenn P. Muir report?
Glenn P. Muir reported receiving 995 restricted stock units and stock options for 2,239 shares of Repligen common stock as equity compensation, with no open-market buying or selling. These awards increase his direct equity exposure to the company.
What are the terms of Glenn P. Muir’s new stock options in REPLIGEN CORP (RGEN)?
Muir received stock options on 2,239 shares of Repligen common stock with an exercise price of $103.38 per share and an expiration date of May 14, 2036. The options vest on the same schedule as his restricted stock units.
When do Glenn P. Muir’s new restricted stock units in REPLIGEN CORP (RGEN) vest?
The 995 restricted stock units vest in full on the earlier of May 14, 2027, one year from the grant date, or the date of Repligen’s next annual shareholder meeting. This creates a time-based vesting incentive linked to his continued board service.
How will Glenn P. Muir’s restricted stock units in REPLIGEN CORP (RGEN) be settled?
Each of the 995 restricted stock units represents a right to receive one Repligen common share. After vesting, the shares will be issued following Muir’s separation from board service, under the company’s Deferred Compensation Plan for Non-Employee Directors.